Scott Greenberg, co-founder and CEO of Bento Box Entertainment, a unit of Fox, will serve as CEO of Blockchain Creative Labs.

Hillel Olivestone, Cross River’s head of corporate development, will run unit.

Bristol Myers Squibb was among the participants in cellular therapy developer Clade Therapeutics' series A round, with the proceeds to go to platform development.

Cancer drug developer Parthenon Therapeutics secured the funding in a series A round co-led by Pfizer Ventures and Taiho Ventures.

Cox Enterprises invested in digital media company Axios at a $430m valuation while Bristol Myers Squibb helped enzyme drug developer Nitrase Therapeutics boost its series A round to $45m.

Rohit Giri left a director of corporate development role at BigCommerce to take up a similar position at Splunk, where he will help run its Splunk Ventures unit.

Coca-Cola paid $5.6bn for the 85% of the sports drink brand it did not already own, having invested an undisclosed amount three years ago.

Google, Kroger and SoftBank Vision Fund 1 all contributed to the autonomous vehicle developer's series D round at a reported $8.6bn valuation.

Gilead and BeiGene participated in a round for the immuno-oncology therapeutics developer in a round that came seven months after it raised $43m.

FTX helped Chipper add $150m to a series C round valuing the cross-border payment platform developer at over $2bn.